₱900 flat-rate shipping on orders above ₱3,500

*VALID ONLY ON ORDERS ABOVE ₱3,500. Ensure cart value is at least ₱3,500 after discounts to see shipping option at check-out. Ships in 3-6 weeks, opt for standard shipping for a faster shipping option. Offer cannot be combined with other offers or discounts. Not valid for cash or cash equivalent and is not good towards any previous purchase. Offer is subject to change without notice. Other restrictions may apply.

Get 10% off all year round! Join Thryft Club
Get 10% off all year round and $10 off your next order! Join Thryft Club
Buy 3 Get Another Free On All Under ₱440
New

The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug

Regular price ₱589.05
Unit price
per
Compare to estimated retail price: ₱1,390.05 PHP  

Pioneering pharma's quest for groundbreaking drugs.

If you're fascinated by the intersection of science and business, "The Billion-Dollar Molecule" could be just the narrative you're looking for. Barry Werth offers an insider's view into the high-stakes world of pharmaceutical development, filled with intense competition and thrilling scientific innovation. It’s a compelling dive into how drugs that could change the world are created and commercialized.

Note: While we do our best to ensure the accuracy of cover images, ISBNs may at times be reused for different editions of the same title which may hence appear as a different cover.
New

The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug

Regular price ₱589.05
Unit price
per
Compare to estimated retail price: ₱1,390.05 PHP  
ISBN: 9780671510572
Authors: Barry Werth
Publisher: Simon & Schuster
Date of Publication: 1995-03-01
Format: Paperback
Related Collections: Science, Business, Biographies & Memoirs
Goodreads rating: 3.93
(rated by 973 readers)

Description

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Condition guide
 

Pioneering pharma's quest for groundbreaking drugs.

If you're fascinated by the intersection of science and business, "The Billion-Dollar Molecule" could be just the narrative you're looking for. Barry Werth offers an insider's view into the high-stakes world of pharmaceutical development, filled with intense competition and thrilling scientific innovation. It’s a compelling dive into how drugs that could change the world are created and commercialized.

Note: While we do our best to ensure the accuracy of cover images, ISBNs may at times be reused for different editions of the same title which may hence appear as a different cover.